UBS Group AG - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNOW and the CUSIP is 834203119. A total of 5 filers reported holding SOLENO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$6,000
+200.0%
52,091
+460.3%
0.00%
Q2 2017$2,0009,2970.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Vivo Capital, LLC 943,858$112,0000.02%
Bollard Group LLC 10,985$1,0000.00%
UBS Group AG 52,091$6,0000.00%
Hudson Bay Capital Management LP 30,000$4,0000.00%
Virtu Financial LLC 12,516$1,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders